Klaria Pharma Holding Stock Revenue
| KLAR Stock | SEK 0.40 0.05 14.29% |
Klaria Pharma Holding fundamentals help investors to digest information that contributes to Klaria Pharma's financial success or failures. It also enables traders to predict the movement of Klaria Stock. The fundamental analysis module provides a way to measure Klaria Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Klaria Pharma stock.
Klaria |
Klaria Pharma Holding Company Revenue Analysis
Klaria Pharma's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Klaria Pharma Holding reported 0.0 of revenue. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Specialty & Generic industry. The revenue for all Sweden stocks is 100.0% higher than that of the company.
Klaria Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Klaria Pharma's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Klaria Pharma could also be used in its relative valuation, which is a method of valuing Klaria Pharma by comparing valuation metrics of similar companies.Klaria Pharma is currently under evaluation in revenue category among its peers.
Klaria Fundamentals
| Return On Equity | -0.88 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (9.48) % | |||
| Current Valuation | 88.14 M | |||
| Shares Outstanding | 63.1 M | |||
| Shares Owned By Insiders | 10.73 % | |||
| Shares Owned By Institutions | 9.75 % | |||
| Price To Earning | (18.43) X | |||
| Price To Book | 1.42 X | |||
| Price To Sales | 8.00 X | |||
| Gross Profit | 5.87 M | |||
| EBITDA | (39.41 M) | |||
| Net Income | (53.53 M) | |||
| Cash And Equivalents | 25.49 M | |||
| Cash Per Share | 0.47 X | |||
| Total Debt | 1.02 M | |||
| Current Ratio | 0.68 X | |||
| Book Value Per Share | 0.97 X | |||
| Cash Flow From Operations | (24.8 M) | |||
| Earnings Per Share | (1.72) X | |||
| Beta | 0.39 | |||
| Market Capitalization | 39.49 M | |||
| Total Asset | 118.31 M | |||
| Retained Earnings | (9 M) | |||
| Working Capital | 41 M | |||
| Current Asset | 44 M | |||
| Current Liabilities | 3 M | |||
| Z Score | 22.8 | |||
| Net Asset | 118.31 M |
About Klaria Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Klaria Pharma Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klaria Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Klaria Pharma Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.